Tag Archives: IGXT

Analysts Offer Insights on Healthcare Companies: IntelGenx Technologies (Other OTC: IGXT), Aerpio Pharmaceuticals (NASDAQ: ARPO) and Medtronic (NYSE: MDT)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IntelGenx Technologies (IGXT – Research Report), Aerpio Pharmaceuticals (ARPO – Research Report) and Medtronic (MDT – Research Report). IntelGenx Technologies (IGXT) In a

Echelon Wealth Partners Maintains Their Buy Rating on IntelGenx Technologies (IGXT)

In a report issued on November 8, Douglas Loe from Echelon Wealth Partners maintained a Buy rating on IntelGenx Technologies (IGXT – Research Report), with a price target of C$1.60. The company’s shares closed last Monday at $0.59. According to

IntelGenx Technologies (IGXT) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on IntelGenx Technologies (IGXT – Research Report) today and set a price target of $1.00. The company’s shares closed last Monday at $0.62. According to TipRanks.com, Ramakanth has currently no stars

H.C. Wainwright Reaffirms Their Buy Rating on IntelGenx Technologies (IGXT)

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on IntelGenx Technologies (IGXT – Research Report) today and set a price target of $1. The company’s shares closed on Friday at $0.41, close to its 52-week low of $0.39. According

Maxim Group Maintains Their Buy Rating on IntelGenx Technologies (IGXT)

Maxim Group analyst Jason McCarthy maintained a Buy rating on IntelGenx Technologies (IGXT – Research Report) yesterday and set a price target of $1.50. The company’s shares closed yesterday at $0.41, close to its 52-week low of $0.39. McCarthy observed:

Analysts Offer Insights on Healthcare Companies: IntelGenx Technologies (Other OTC: IGXT), Avrobio Inc (NASDAQ: AVRO) and Concert Pharma (NASDAQ: CNCE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IntelGenx Technologies (IGXT – Research Report), Avrobio Inc (AVRO – Research Report) and Concert Pharma (CNCE – Research Report) with bullish sentiments.